NeoPhotonics (NPTN) Updates Q4 Earnings Guidance

Share on StockTwits

NeoPhotonics (NYSE:NPTN) issued an update on its fourth quarter earnings guidance on Monday morning. The company provided earnings per share guidance of $0.00-0.04 for the period, compared to the Thomson Reuters consensus earnings per share estimate of ($0.03). The company issued revenue guidance of $90-92 million, compared to the consensus revenue estimate of $89.58 million.

NYSE NPTN opened at $7.18 on Monday. The company has a market capitalization of $326.95 million, a price-to-earnings ratio of -6.53 and a beta of 1.25. NeoPhotonics has a fifty-two week low of $4.95 and a fifty-two week high of $9.48. The company has a debt-to-equity ratio of 0.31, a current ratio of 2.04 and a quick ratio of 1.51.

NeoPhotonics (NYSE:NPTN) last released its quarterly earnings results on Friday, November 2nd. The semiconductor company reported ($0.05) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.19) by $0.14. The firm had revenue of $81.75 million during the quarter, compared to analysts’ expectations of $82.60 million. NeoPhotonics had a negative return on equity of 26.53% and a negative net margin of 16.60%. NeoPhotonics’s quarterly revenue was up 14.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.14) EPS. As a group, sell-side analysts forecast that NeoPhotonics will post -0.82 earnings per share for the current fiscal year.

NPTN has been the subject of a number of analyst reports. ValuEngine cut NeoPhotonics from a strong-buy rating to a buy rating in a report on Monday, September 17th. Rosenblatt Securities set a $13.00 price target on NeoPhotonics and gave the stock a buy rating in a report on Monday, December 10th. B. Riley upped their price target on NeoPhotonics from $10.00 to $11.00 and gave the stock a buy rating in a report on Monday, November 5th. Craig Hallum set a $10.00 price target on NeoPhotonics and gave the stock a buy rating in a report on Monday, November 5th. Finally, Zacks Investment Research cut NeoPhotonics from a buy rating to a hold rating in a research note on Friday, November 9th. Four equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company has an average rating of Buy and an average target price of $9.53.

TRADEMARK VIOLATION NOTICE: “NeoPhotonics (NPTN) Updates Q4 Earnings Guidance” was first posted by BBNS and is owned by of BBNS. If you are accessing this article on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright law. The legal version of this article can be read at https://baseballnewssource.com/2019/01/14/neophotonics-nptn-updates-q4-earnings-guidance/3140119.html.

NeoPhotonics Company Profile

NeoPhotonics Corporation develops, manufactures, and sells optoelectronic products that transmit, receive, and switch high speed digital optical signals for communications networks. It offers high speed products, including transmitter, receiver, and switching products for 100G (gigabits per second) and optical transmission applications over distances of 2 to 2,000 kilometers; optical components for coherent systems, including narrow linewidth tunable transmit and local oscillator lasers (NLW-ITLA) that generate ultra-pure wavelength or color for coherent transmission, as well as coherent micro-modulators, which encode the information on the intensity and phase of the optical beam; and integrated coherent receivers (ICRs) that decode the phase and polarization encoded coherent signals.

Further Reading: Debt-To-Equity Ratio

Receive News & Ratings for NeoPhotonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeoPhotonics and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2019 BBNS.